Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

Investing in biotechnology often feels like navigating a minefield. A single failed clinical trial can decimate a stock, ...

The 3D cell culture market is projected to witness remarkable expansion, reaching an estimated USD 2.26 billion by 2030 from ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes ...

Krystal Biotech, Inc. announced that it will present multiple research programs focused on lung, eye, and skin conditions at several scientific conferences in May and June 2025. The presentations ...

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. The Cambridge, Massachusetts-based biotech is also laying off staffers and CEO Keith ...

Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Prime Medicine, Inc. (NASDAQ:PRME) stands against the other ...

North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...

Regenerative Medicine in India is revolutionising healthcare through stem cell therapy, gene editing, and tissue engineering, ...